DOCSLIB.ORG

Investigation of RNA Quality Control Pathways in RNP Hypo-Assembly

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Investigation of RNA Quality Control Pathways in RNP Hypo-Assembly Investigation of RNA quality control pathways in RNP hypo-assembly diseases by Siddharth Shukla Integrated M.Sc., Indian Institute of Technology Bombay, 2011 A thesis submitted to the Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirement for the degree of Doctor of Philosophy Department of Chemistry and Biochemistry 2016 i This thesis entitled: Investigation of RNA quality control pathways in RNP hypo-assembly diseases written by Siddharth Shukla has been approved for the Department of Chemistry and Biochemistry ________________________________ Roy Parker ________________________________ James Goodrich Date ___________ The final copy of this thesis has been examined by the signatories, and we find that both the content and the form meet acceptable presentation standards of scholarly work in the above mentioned discipline. ii Shukla, Siddharth (Ph.D., Biochemistry) Investigation of RNA quality control pathways in RNP hypo-assembly diseases Thesis directed by Professor Roy Parker A key aspect of cellular function is the proper assembly and utilization of ribonucleoproteins (RNPs). Defects in the formation of RNPs lead to "RNP hypo- assembly diseases", which can be caused by RNA degradation out-competing RNP assembly. Examples of such human diseases include Dyskeratosis Congenita (DC) and Spinal Muscular Atrophy (SMA). In order to test the hypothesis that specific RNA quality control pathways were responsible for degradation of RNAs in these diseases, I used yeast and mammalian cell lines as model systems to investigate two different diseases, SMA and DC. In SMA, Sm-site mutations in yeast U1 snRNA led to their rapid degradation by two different RNA decay pathways: 3’ to 5’ decay in the nucleus by Trf4/Rrp6, and 5’ to 3’ decay in the cytoplasm by Dcp2/Xrn1. Cytoplasmic degradation of snRNAs when the Sm site is mutated is conserved in human cells. The cytoplasmic decay pathway is also responsible for the degradation of snRNAs when SMN levels are reduced, as is the case in SMA. Importantly, inhibition of snRNA decapping through DCP2 knockdown rescued splicing defects observed for some mRNAs when SMN is limiting. These results suggest that inhibition of snRNA decay could rescue some phenotypes of SMA. For the investigation of human telomerase RNA (hTR) quality control pathways in DC, disease causing mutations were introduced in hTR, along with the depletion of dyskerin in human cells. These models established that hTR is degraded by PAPD5/EXOSC10 in the nucleus, and DCP2/XRN1 in the cytoplasm. Inhibition of hTR decay rescued both the sub-cellular localization of hTR, as well as telomerase activity in iii human cells. Additionally, PARN, which is a 3’ to 5’ exonuclease, stabilized hTR through deadenylation of its 3’ end. PARN mutations also lead to a severe form of DC. I have identified other possible substrates of PARN in human cells, which suggest that PARN deadenylates a number of stable non coding RNAs in human cells, but influences the stability of a select few. This potentially explains why PARN mutations cause a more severe form of DC than mutations in telomerase components. iv Acknowledgements Pursuing graduate school was not something I had anticipated till the third year of my undergraduate studies, so I feel a deep sense of gratitude towards a number of provocative mentors and supportive friends for invigorating this zeal for scientific research. I thank my thesis advisor, Roy, for leading by example on this pursuit of fundamental knowledge of our cells and their various minutiae. I have learned skills from Roy that will be useful not only in the lab, but also outside of it- asking the right questions, questioning conventional knowledge when necessary, and pushing yourself to be as efficient as you can be, to name a few. I also thank Roy for giving me a chance to spend a summer in his lab during my undergraduate studies, an opportunity that ultimately led to five years of graduate school culminating in this thesis. I thank my Master’s thesis advisor, Dr. P.I. Pradeepkumar, for mentoring me during my undergraduate studies at IIT Bombay, and providing me with a sound exposure to biological research, which was otherwise impossible to get in a core chemistry department. I also thank the former members of his lab, Dr. Kiran Gore, Dr. V. Dhamodharan and Dr. Jagdeesh Chandrashekhar, for teaching me the skills that were of great utility in graduate school. For an international student 9,000 miles away from the comfort of the native culture, the lab becomes family. I am extremely grateful to have had the good fortune of being a part of a supportive lab with talented and caring people all around me. It is a testament to the people here that we function more as a unit and less as a group of individuals pursuing their own research. I will cherish all the random chats about America and food, as well as the discussions and feedback over my research. I v especially want to thank two former members, Dr. Ross Buchan and Dr. Saumya Jain, for life-long memories and friendship. I thank the members of my thesis committee for being so supportive and helpful over the last two years, and providing me your valuable insight which has fostered new ideas and directions in my research. I especially want to thank Tom for his input and guidance during my study of human telomerase RNA quality control, which has now become a fruitful collaboration. I also thank the members of the Cech lab for their help during the course of this collaboration. Last but not the least, I want to express my love and gratitude to friends and family back home. Thank you mummy and papa for supporting me in all of my pursuits, even those that did not pan out. Thank you for never letting anything get in the way of my studies and research, even when times were hard. I thank my younger brother, Rishabh, for being the best sibling one could ask for. I am very proud of the person and the doctor he has become, and his hard work and dedication motivates me when things are not going smoothly. Finally, I thank my girlfriend Navneeta, for five wonderful years of companionship and love, which have been a source of comfort and inspiration. Life would not be what it is without you in it! vi Table of Contents Chapter 1: Hypo-assembly diseases of RNA-protein complexes .............................. 1 RNA quality control pathways compete with RNP assembly ................................. 1 Introduction ............................................................................................................... 1 Diversity of RNA quality control pathways in eukaryotes .......................................... 4 Hypo-assembly diseases of RNPs .......................................................................... 11 Dyskeratosis Congenita and degradation of telomerase RNA ................................ 11 Spinal Muscular Atrophy and snRNA degradation .................................................. 14 RNP hypo-assembly diseases include pathologies of ncRNAs ........................... 18 Hypo-assembly diseases of mRNPs ....................................................................... 20 Discovery of possible treatments for RNP hypo-assembly diseases ................. 23 Conclusion ................................................................................................................ 24 Chapter 2: Quality control of snRNAs in Spinal Muscular Atrophy ........................ 25 Summary ................................................................................................................... 25 SMA is a neurodegenerative disease caused by snRNP deficiency ................... 26 Results ....................................................................................................................... 28 Mutations in the yeast U1 snRNA Sm site destabilize the snRNA .......................... 28 Defective U1 snRNAs are degraded by both 3' to 5' exonuclease Rrp6 and decapping and Xrn1-mediated decay ..................................................................... 30 Decapping of defective U1 snRNAs in yeast is catalyzed by the Dcp2 enzyme ..... 36 Decapping and 5' to 3' degradation of defective snRNAs is conserved in mammalian cells...................................................................................................... 38 vii Reduction of snRNA levels by SMN knockdown can be rescued by inhibition of decapping and XRN1-mediated decay ................................................................... 42 Knockdown of DCP2 partially suppresses some SMN knockdown dependent splicing defects ........................................................................................................ 45 Discussion ................................................................................................................. 49 Assembly-defective snRNAs are subject to quality control ..................................... 49 Defects in snRNP assembly in mammals leads to decapping and 5' to 3' decay ... 49 Prevention of snRNA decapping may lead to rescue of snRNP function ................ 51 RNP biogenesis generally competes with quality control ........................................ 52 Experimental methods ............................................................................................. 53 Construction of U1 Sm-mutants in yeast and mammals ......................................... 53 Yeast strains and plasmids ....................................................................................
Load more

Recommended publications
  • IP6K1 Upregulates the Formation of Processing Bodies by Promoting Proteome Remodeling on the Mrna Cap
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.199828; this version posted July 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. IP6K1 upregulates the formation of processing bodies by promoting proteome remodeling on the mRNA cap Akruti Shah1,2 and Rashna Bhandari1* 1Laboratory of Cell Signalling, Centre for DNA Fingerprinting and Diagnostics (CDFD), Inner Ring Road, Uppal, Hyderabad 500039, India. 2Graduate studies, Manipal Academy of Higher Education, Manipal 576104, India. *Correspondence to Rashna Bhandari; Email: [email protected] Running title: IP6K1 promotes mRNA turnover to induce P-bodies ORCID IDs Akruti Shah - 0000-0001-9557-4952 Rashna Bhandari - 0000-0003-3101-0204 This PDF file includes: Main Text Figures 1 to 6 Keywords mRNA decay/mRNA metabolism/P-bodies/translation suppression 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.199828; this version posted July 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Inositol hexakisphosphate kinases (IP6Ks) are ubiquitously expressed small molecule kinases that catalyze the conversion of the inositol phosphate IP6 to 5-IP7. IP6Ks have been reported to influence cellular functions by protein-protein interactions independent of their enzymatic activity.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Comprehensive Protein Interactome Analysis of a Key RNA Helicase: Detection of Novel Stress Granule Proteins
    Biomolecules 2015, 5, 1441-1466; doi:10.3390/biom5031441 OPEN ACCESS biomolecules ISSN 2218-273X www.mdpi.com/journal/biomolecules/ Article Comprehensive Protein Interactome Analysis of a Key RNA Helicase: Detection of Novel Stress Granule Proteins Rebecca Bish 1,†, Nerea Cuevas-Polo 1,†, Zhe Cheng 1, Dolores Hambardzumyan 2, Mathias Munschauer 3, Markus Landthaler 3 and Christine Vogel 1,* 1 Center for Genomics and Systems Biology, Department of Biology, New York University, 12 Waverly Place, New York, NY 10003, USA; E-Mails: [email protected] (R.B.); [email protected] (N.C.-P.); [email protected] (Z.C.) 2 The Cleveland Clinic, Department of Neurosciences, Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA; E-Mail: [email protected] 3 RNA Biology and Post-Transcriptional Regulation, Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Robert-Rössle-Str. 10, Berlin 13092, Germany; E-Mails: [email protected] (M.M.); [email protected] (M.L.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-212-998-3976; Fax: +1-212-995-4015. Academic Editor: André P. Gerber Received: 10 May 2015 / Accepted: 15 June 2015 / Published: 15 July 2015 Abstract: DDX6 (p54/RCK) is a human RNA helicase with central roles in mRNA decay and translation repression. To help our understanding of how DDX6 performs these multiple functions, we conducted the first unbiased, large-scale study to map the DDX6-centric protein-protein interactome using immunoprecipitation and mass spectrometry. Using DDX6 as bait, we identify a high-confidence and high-quality set of protein interaction partners which are enriched for functions in RNA metabolism and ribosomal proteins.
    [Show full text]
  • Unraveling Regulation and New Components of Human P-Bodies Through a Protein Interaction Framework and Experimental Validation
    Downloaded from rnajournal.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press PERSPECTIVE Unraveling regulation and new components of human P-bodies through a protein interaction framework and experimental validation DINGHAI ZHENG,1,2 CHYI-YING A. CHEN,1 and ANN-BIN SHYU3 Department of Biochemistry and Molecular Biology, The University of Texas Medical School, Houston, Texas 77021, USA ABSTRACT The cellular factors involved in mRNA degradation and translation repression can aggregate into cytoplasmic domains known as GW bodies or mRNA processing bodies (P-bodies). However, current understanding of P-bodies, especially the regulatory aspect, remains relatively fragmentary. To provide a framework for studying the mechanisms and regulation of P-body formation, maintenance, and disassembly, we compiled a list of P-body proteins found in various species and further grouped both reported and predicted human P-body proteins according to their functions. By analyzing protein–protein interactions of human P-body components, we found that many P-body proteins form complex interaction networks with each other and with other cellular proteins that are not recognized as P-body components. The observation suggests that these other cellular proteins may play important roles in regulating P-body dynamics and functions. We further used siRNA-mediated gene knockdown and immunofluorescence microscopy to demonstrate the validity of our in silico analyses. Our combined approach identifies new P-body components and suggests that protein ubiquitination and protein phosphorylation involving 14-3-3 proteins may play critical roles for post-translational modifications of P-body components in regulating P-body dynamics. Our analyses provide not only a global view of human P-body components and their physical interactions but also a wealth of hypotheses to help guide future research on the regulation and function of human P-bodies.
    [Show full text]
  • Rabbit Anti-DCP1A/FITC Conjugated Antibody
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-DCP1A/FITC Conjugated antibody SL10788R-FITC Product Name: Anti-DCP1A/FITC Chinese Name: FITC标记的脱帽酶1A抗体 DCP1 decapping enzyme homolog A; Dcp1a; DCP1A_HUMAN; mRNA decapping enzyme 1A; mRNA-decapping enzyme 1A; Smad4 interacting transcriptional co Alias: activator; Smad4-interacting transcriptional co-activator; Smad4-interacting transcriptional co-activator; SMAD4IP1; SMIF; Transcription factor SMIF. Organism Species: Rabbit Clonality: Polyclonal React Species: ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 63kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human DCP1A Lsotype: IgG Purification: affinitywww.sunlongbiotech.com purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: Cleavage of the 5'-cap structure is involved in the major 5'-to-3' and nonsense-mediated mRNA decay pathways. The protein complex consisting of Dcp1 and Dcp2 has been Product Detail: identified as the species responsible for the decapping reaction in Saccharomyces cerevisiae. In nonsense-mediated decay, the human decapping complex, made up of S.
    [Show full text]
  • RHNO1 Bidirectional Genes in Cancer
    RESEARCH ARTICLE Co-regulation and function of FOXM1/ RHNO1 bidirectional genes in cancer Carter J Barger1, Linda Chee1, Mustafa Albahrani1, Catalina Munoz-Trujillo1, Lidia Boghean1, Connor Branick1, Kunle Odunsi2, Ronny Drapkin3, Lee Zou4, Adam R Karpf1* 1Eppley Institute for Cancer Research and Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States; 2Departments of Gynecologic Oncology, Immunology, and Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, United States; 3Penn Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States; 4Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, United States Abstract The FOXM1 transcription factor is an oncoprotein and a top biomarker of poor prognosis in human cancer. Overexpression and activation of FOXM1 is frequent in high-grade serous carcinoma (HGSC), the most common and lethal form of human ovarian cancer, and is linked to copy number gains at chromosome 12p13.33. We show that FOXM1 is co-amplified and co- expressed with RHNO1, a gene involved in the ATR-Chk1 signaling pathway that functions in the DNA replication stress response. We demonstrate that FOXM1 and RHNO1 are head-to-head (i.e., bidirectional) genes (BDG) regulated by a bidirectional promoter (BDP) (named F/R-BDP). FOXM1 and RHNO1 each promote oncogenic phenotypes in HGSC cells, including clonogenic growth, DNA homologous recombination repair, and poly-ADP ribosylase inhibitor resistance. FOXM1 and RHNO1 are one of the first examples of oncogenic BDG, and therapeutic targeting of FOXM1/ RHNO1 BDG is a potential therapeutic approach for ovarian and other cancers. *For correspondence: [email protected] Introduction Competing interests: The The forkhead/winged helix domain transcription factor FOXM1 promotes cancer by transactivating authors declare that no genes with oncogenic potential (Halasi and Gartel, 2013a; Kalathil et al., 2020).
    [Show full text]
  • Set2-Mediated Alternative Splicing of Srsf11 Regulates Cocaine Reward Behavior
    bioRxiv preprint doi: https://doi.org/10.1101/798009; this version posted October 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Graphic Legend: Epigenetic editing enriches H3K36me3 at the gene for Srsf11, a splice factor. Enrichment of H3K36me3 causes alternative splicing of Srsf11, in the form of increased intron retention. After this manipulation in a brain reward region, mice show greater preference for a cocaine reward. bioRxiv preprint doi: https://doi.org/10.1101/798009; this version posted October 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Summary Alternative splicing is a key mechanism for neuronal gene regulation, and is grossly altered in mouse brain reward regions following investigator-administered cocaine. It is well established that cocaine epigenetically regulates transcription, yet mechanism(s) by which cocaine-induced epigenetic modifications regulate alternative splicing is largely unexplored. Our group and others have previously identified the histone modification, H3K36me3, as a putative splicing regulator. However, it has not yet been possible to establish the direct causal relevance of this modification to alternative splicing in brain or any other context. We found that mouse cocaine self-administration caused widespread alternative splicing, concomitant with enrichment of H3K36me3 at splice junctions.
    [Show full text]
  • The Dynamics of Mammalian P Body Transport, Assembly, and Disassembly in Vivo Adva Aizer,* Yehuda Brody,* Lian Wee Ler,† Nahum Sonenberg,† Robert H
    Molecular Biology of the Cell Vol. 19, 4154–4166, October 2008 The Dynamics of Mammalian P Body Transport, Assembly, and Disassembly In Vivo Adva Aizer,* Yehuda Brody,* Lian Wee Ler,† Nahum Sonenberg,† Robert H. Singer,‡ and Yaron Shav-Tal* *The Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 52900, Israel; †Department of Biochemistry and McGill Cancer Center, McGill University, Montreal, Quebec H3G 1Y6, Canada; and ‡Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY 10461 Submitted May 22, 2008; Revised July 14, 2008; Accepted July 15, 2008 Monitoring Editor: Marvin Wickens Exported mRNAs are targeted for translation or can undergo degradation by several decay mechanisms. The 5؅33؅ degradation machinery localizes to cytoplasmic P bodies (PBs). We followed the dynamic properties of PBs in vivo and investigated the mechanism by which PBs scan the cytoplasm. Using proteins of the decapping machinery, we asked whether PBs actively scan the cytoplasm or whether a diffusion-based mechanism is sufficient. Live-cell imaging showed that PBs were anchored mainly to microtubules. Quantitative single-particle tracking demonstrated that most PBs exhibited spatially confined motion depen- dent on microtubule motion, whereas stationary PB pairs were identified at the centrosome. Some PBs translocated in long-range movements on microtubules. PB mobility was compared with mitochondria, endoplasmic reticulum, peroxisomes, SMN bodies, and stress granules, and diffusion coefficients were calculated. Disruption of the microtubule network caused a significant reduction in PB mobility together with an induction of PB assembly. However, FRAP measurements showed that the dynamic flux of assembled PB components was not affected by such treatments.
    [Show full text]
  • Tracks Through the Genome to Physiological Events
    Exp Physiol 100.12 (2015) pp 1429–1440 1429 Review Article Tracks through the genome to physiological events Diane Lipscombe1,JenQ.Pan2 and Stephanie Schorge3 1Department of Neuroscience, Brown University, Providence, RI, USA 2Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA 3University College London Institute of Neurology, London, UK Diane Lipscombe is Professor of Neuroscience and interim Director of the Brown Institute for Brain Science. Member-at-Large and Fellow of the American Association for the Advancement of Science, Diane received the 2012 Joan Mott Prize from the Physiological Society and the Harriet W. Sheridan Award for Distinguished Contribution to Teaching and Learning at Brown University. Diane Lipscombe is nationally recognized for her research on voltage-gated calcium ion channels from genes to behaviour, including cell-specific pre-mRNA processing. Diane Lipscombe obtained her BSc and PhD degrees in Pharmacology from University College London and completed her postdoctoral training in Physiology at Yale University and Stanford University Schools of Medicine. New Findings r What is the topic of this review? We discuss tools available to access genome-wide data sets that harbour cell-specific, brain region-specific and tissue-specific information on exon usage for several species, including humans. In this Review, we demonstrate how to access this information in genome databases Physiology and its enormous value to physiology. r What advances does it highlight? The sheer scale of protein diversity that is possible from complex genes, including those that encode voltage-gated ion channels, is vast. But this choice is critical for a complete understanding of protein function in the most physiologically relevant context.
    [Show full text]
  • Network-Based Analysis of Key Regulatory Genes Implicated in Type
    www.nature.com/scientificreports OPEN Network‑based analysis of key regulatory genes implicated in Type 2 Diabetes Mellitus and Recurrent Miscarriages in Turner Syndrome Anam Farooqui1, Alaa Alhazmi2, Shaful Haque3, Naaila Tamkeen4, Mahboubeh Mehmankhah1, Safa Tazyeen1, Sher Ali5 & Romana Ishrat1* The information on the genotype–phenotype relationship in Turner Syndrome (TS) is inadequate because very few specifc candidate genes are linked to its clinical features. We used the microarray data of TS to identify the key regulatory genes implicated with TS through a network approach. The causative factors of two common co‑morbidities, Type 2 Diabetes Mellitus (T2DM) and Recurrent Miscarriages (RM), in the Turner population, are expected to be diferent from that of the general population. Through microarray analysis, we identifed nine signature genes of T2DM and three signature genes of RM in TS. The power‑law distribution analysis showed that the TS network carries scale‑free hierarchical fractal attributes. Through local‑community‑paradigm (LCP) estimation we fnd that a strong LCP is also maintained which means that networks are dynamic and heterogeneous. We identifed nine key regulators which serve as the backbone of the TS network. Furthermore, we recognized eight interologs functional in seven diferent organisms from lower to higher levels. Overall, these results ofer few key regulators and essential genes that we envisage have potential as therapeutic targets for the TS in the future and the animal models studied here may prove useful in the validation of such targets. Te medical systems and scientists throughout the world are under an unprecedented challenge to meet the medical needs of much of the world’s population that are sufering from chromosomal anomalies.
    [Show full text]
  • Gene Expression Responses of Larval Gopher (Sebastes Carnatus) and Blue (S
    California State University, Monterey Bay Digital Commons @ CSUMB Capstone Projects and Master's Theses Capstone Projects and Master's Theses Fall 2020 Gene Expression Responses of Larval Gopher (Sebastes carnatus) and Blue (S. mystinus) Rockfish ot Ocean Acidification and Hypoxia Jacoby Baker Follow this and additional works at: https://digitalcommons.csumb.edu/caps_thes_all This Master's Thesis (Open Access) is brought to you for free and open access by the Capstone Projects and Master's Theses at Digital Commons @ CSUMB. It has been accepted for inclusion in Capstone Projects and Master's Theses by an authorized administrator of Digital Commons @ CSUMB. For more information, please contact [email protected]. GENE EXPRESSION RESPONSES OF LARVAL GOPHER (SEBASTES CARNATUS) AND BLUE (S. MYSTINUS) ROCKFISH TO OCEAN ACIDIFICATION AND HYPOXIA A Thesis Presented to the Faculty of Moss Landing Marine Laboratories California State University Monterey Bay In Partial Fulfillment of the Requirements for the Degree Master of Science in Marine Science by Jacoby Baker Fall 2020 CALIFORNIA STATE UNIVERSITY MONTEREY BAY The Undersigned Faculty Committee Approves the Thesis of Jacoby Baker: GENE EXPRESSION RESPONSES OF LARVAL GOPHER (SEBASTES CARNATUS) AND BLUE (S. MYSTINUS) ROCKFISH TO OCEAN ACIDIFICATION AND HYPOXIA Scott Hamilton, Chair Moss Landing Marine Laboratories Cheryl Logan, Primary Research Advisor California State Monterey Bay Jonathan Geller Moss Landing Marine Laboratories Nathaniel Jue California State Monterey Bay Daniel Shapiro, Interim Dean Associate VP for Academic Programs and Dean of Undergraduate and Graduate Studies 12/11/2020 Approval Date iii Copyright © 2020 by Jacoby Baker All Rights Reserved iv ABSTRACT Gene Expression Responses of Larval Gopher (Sebastes carnatus) and Blue (S.
    [Show full text]